CONSORT Harms 2022 statement, explanation, and elaboration: updated guideline for the reporting of harms in randomised trials.

Daniela R JunqueiraLiliane ZorzelaSusan GolderYoon LokeJoel J GagnierSteven A JuliousTianjing LiEvan Mayo-WilsonBa PhamRachel PhillipsPasqualina SantaguidaRoberta W SchererPeter C GøtzscheDavid MoherJohn P A IoannidisSunita Vohranull null

Published in: BMJ (Clinical research ed.) (2023)

Keyphrases

clinical trial
open label
adverse drug
double blind
placebo controlled
randomized controlled trial
emergency department